Skip Page Banner  
INTELLECTUAL PROPERTY
BLOG

 

Friday, April 26, 2013

If High Court Nixes Myriad Gene Patent, Look to Decades of Uncertainty, Panel Says

RSS

Bloomberg BNA full story: 

A contribution by John T. Aquino, who writes for Bloomberg BNA's Life Sciences Law and Industry and Medical Research Law and Policy Report on a panel discussion after the Myriad oral argument, appearing in BNA's Patent, Trademark & Copyright Law Daily (accessible to both subscribers and non-subscribers).

Subscription RequiredAll BNA publications are subscription-based and require an account. If you are a subscriber to the BNA publication and signed-in, you will automatically have access to the story. If you are not a subscriber, you will need to sign-up for a trial subscription.

You must Sign In or Register to post a comment.

Comments (0)